Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.59 |
| ▸ | CTSD | P07339 | 10/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3172037 | 0.88 | BACE1 (0.77) | BACE1CTSDCYP3A4 | |
| SCHEMBL3168249 | 0.88 | BACE1 (0.77) | BACE1CTSDCYP3A4 | |
| SCHEMBL3167544 | 0.88 | BACE1 (0.77) | BACE1CTSDCYP3A4 | |
| Hydrochloric Acid SCHEMBL3175823 | 0.87 | BACE1 (0.75) | BACE1CTSDCYP3A4 | |
| Hydrochloric Acid SCHEMBL3175815 | 0.87 | BACE1 (0.75) | BACE1CTSDCYP3A4 | |
| SCHEMBL3353712 | 0.87 | BACE1 (0.64) | BACE1CTSDCYP3A4 | |
| SCHEMBL3353705 | 0.87 | BACE1 (0.64) | BACE1CTSDCYP3A4 | |
| SCHEMBL13316013 | 0.85 | BACE1 (0.52) | BACE1CTSDCYP3A4 | |
| SCHEMBL14508445 | 0.85 | BACE1 (0.60) | BACE1CTSDCYP3A4 | |
| SCHEMBL3503456 | 0.84 | BACE1 (0.80) | BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070105921-A1 | Process for Preparing Oxazole Intermediates | PHARMACIA & UPJOHN COMPANY | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105921-A1 | Process for Preparing Oxazole Intermediates | OXA1L, SOD1, PSEN1 | BACE1 7/4885CTSD 3891/4885CYP3A4 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.